Region Örebro County
Quick facts
Marketed products
- Clonidine Oral Liquid Product · Cardiovascular
Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic nervous system activity by stimulating alpha-2 receptors in the brain and periphery. - FSME-IMMUN Vaccine · Immunology / Infectious Disease
FSME-IMMUN is an inactivated tick-borne encephalitis virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against TBEV. - I/T morphine · Pain management
Morphine binds to opioid receptors in the central and peripheral nervous system to produce analgesia and sedation. - PlaceboMNTX
PlaceboMNTX is a placebo formulation with no active pharmacological mechanism. - RemifentanilMNTX · Anesthesia/Analgesia
RemifentanilMNTX is a combination of remifentanil (a potent opioid agonist) and methylnaltrexone (a peripheral mu-opioid receptor antagonist) designed to provide analgesia while reducing opioid-induced side effects.
Phase 3 pipeline
- CDK 4/6 inhibitors · Oncology
CDK 4/6 inhibitors block cyclin-dependent kinases 4 and 6, which prevents phosphorylation of the retinoblastoma protein and halts cell cycle progression at the G1/S checkpoint. - Placebo Tab
Placebo produces no pharmacological effect, serving as an inert control to measure the psychological and contextual benefits of treatment. - ropivacaine, ketorelac and epinephrine · Pain management
Ropivacaine is a local anesthetic that blocks nerve impulses, while ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation, and epinephrine is a vasoconstrictor that helps to prolong the duration of action of ropivacaine.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: